Clinical trial
A Study of Rabeprazole and Pantoprazole on Stomach Acid and Esophageal Acid…
NCT00237367 · PriCara, Unit of Ortho-McNeil, Inc., Industry · Completed
Key facts
| NCT number | NCT00237367 |
|---|---|
| Title | A Study of Rabeprazole and Pantoprazole on Stomach Acid and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD) and a History of Nighttime Heartburn |
| Official title | A Randomized, Two-way Crossover Study of the Effects of a Single Dose of Rabeprazole or Pantoprazole on 24-hour Intragastric Acidity and Esophageal Acid Exposure in GERD Patients With a History of Nocturnal Heartburn |
| Lead sponsor | PriCara, Unit of Ortho-McNeil, Inc., Industry |
| Collaborators | Eisai Inc. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Gastroesophageal Reflux |
| Intervention type | Drug |
| Interventions | rabeprazole and pantoprazole |
| Enrollment | 52 |
| Completion | Apr 1, 2005 |
| First posted | Oct 12, 2005 |
| Last update posted | Apr 28, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: